Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

31.1K
Overview
31.1K
Hybridoma Technology01:31

Hybridoma Technology

14.8K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.8K
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

829
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
829
Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

595
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
595
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibody-lectin chimeras for glyco-immune checkpoint blockade.

Nature biotechnology·2025
Same author

Valency-affinity mapping of multivalent liposomes for tunable target cell discrimination.

Drug delivery·2025
Same author

Pulsed stimuli enable p53 phase resetting to synchronize single cells and modulate cell fate.

Molecular systems biology·2025
Same author

Syncytial therapeutics: Receptor-specific and direct-to-cytosol biologic drug delivery mediated by measles fusion complex.

Journal of controlled release : official journal of the Controlled Release Society·2025
Same author

Inertial effect of cell state velocity on the quiescence-proliferation fate decision.

NPJ systems biology and applications·2024
Same author

Rapid retinoic acid-induced trophoblast cell model from human induced pluripotent stem cells.

Scientific reports·2024

Related Experiment Video

Updated: Jul 9, 2025

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
06:26

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

1.0K

Designing Multivalent and Multispecific Biologics.

Jennifer J Kang1, Ayako Ohoka1,2, Casim A Sarkar1

  • 1Department of Biomedical Engineering, University of Minnesota, Minneapolis, Minnesota, USA; email: kangx790@umn.edu, ohoka001@umn.edu, csarkar@umn.edu.

Annual Review of Chemical and Biomolecular Engineering
|December 8, 2023
PubMed
Summary
This summary is machine-generated.

Multivalent and multispecific therapeutics offer enhanced efficacy and reduced side effects by targeting multiple disease sites. Optimizing their design is key for precision medicine applications.

More Related Videos

Laboratory Scale Production and Purification of a Therapeutic Antibody
09:54

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

17.5K
Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
13:14

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

10.5K

Related Experiment Videos

Last Updated: Jul 9, 2025

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
06:26

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization

Published on: January 24, 2025

1.0K
Laboratory Scale Production and Purification of a Therapeutic Antibody
09:54

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

17.5K
Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
13:14

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

10.5K

Area of Science:

  • Biomolecular Engineering
  • Chemical Engineering
  • Precision Medicine

Background:

  • Multivalent and multispecific therapeutics are emerging as powerful tools in precision medicine.
  • These advanced biologics target multiple disease-related molecules simultaneously.
  • They offer potential for enhanced therapeutic efficacy, minimized side effects, and overcoming drug resistance.

Purpose of the Study:

  • To analyze the fundamental design principles of multivalent biologics.
  • To identify key challenges and effective strategies for maximizing therapeutic outcomes.
  • To explore current and future applications in protein and cell-based therapies.

Main Methods:

  • Dissecting design principles including domain affinities, valency, and spatial presentation.
  • Balancing target avidity and specificity through careful engineering.
  • Reviewing recent advancements in protein and cell therapy design.

Main Results:

  • Established design principles for multivalent and multispecific biologics.
  • Highlighted the importance of balancing molecular properties for optimal performance.
  • Showcased successful applications in advanced therapeutic development.

Conclusions:

  • Multivalent and multispecific biologics represent a significant advancement in targeted disease intervention.
  • Continued progress in biomolecular engineering and computational methods will drive future innovations.
  • These therapeutics hold great promise for the future of precision medicine.